f.espinoza
TL2 Moderator · Braga
Contributes reviews on supplier material. Based in Braga.
Joined 24 July 2025 · last posted 5d
91Posts here
4Topics
0Solutions
157Likes received
171Likes given
19Badges
80Days visited
441Posts read
Recent activity
Full stream-
What is genuinely unknown about long-term amylin agonism Replied, post #74 · Compounds › Cagrilintide & amylin analogues · 23 Jul 2026 · 19 likes This follows post #71 rather than contradicting it. The dosing interval: cagrilintide's half-life is roughly 7 to 8 days, suitable for weekly dosing. The…
-
[2026 update] Documenting an adverse event properly Replied, post #17 · Safety › Adverse events · 22 Jul 2026 · 16 likes How to document: date, exact symptom or event, severity, duration, outcome, any medical attention sought. Detailed documentation is far more useful than a vague report.
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #79 · Practice › Dosing & titration · 19 Jul 2026 · 1 like How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
-
Travelling with an injectable: documentation and practicalities Replied, post #41 · Access › International · 18 Jul 2026 · 4 likes Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #88 · Start Here › Welcome · 17 Jul 2026 · 6 likes The moderation log is public. Every staff action is logged with the rule cited and the reasoning stated. If you get moderated, the explanation is there and it is worth…
-
What would change my mind about repair peptides: a specific answer Replied, post #25 · Compounds › Repair & healing peptides · 16 Jul 2026 · 9 likes Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are common in supplier marketing and poorly supported by…
-
Why the cheapest option is often not the cheapest Replied, post #14 · Access › Pricing · 29 Jun 2026 · 4 likes International pricing: the same compound costs very different amounts in different countries because healthcare systems and regulatory frameworks differ. Generally, US…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #69 · Wellbeing › Sleep · 26 Jun 2026 · 3 likes Sleep hygiene: basics (cool dark room, consistent sleep time, no screens before bed) matter more during energy deficit because stress and sleep need are higher.
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #71 · Practice › Interactions · 25 Jun 2026 · 0 likes This follows post #68 rather than contradicting it. SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to…
-
Revisiting: Protein density versus volume when you cannot eat much Started this topic · Nutrition & Training › Protein & intake · 21 Jun 2026 · 4 likes Revisiting: Protein density versus volume when you cannot eat much Writing it up because I had to work it out twice and would rather nobody else did. Longitudinal…
-
Why the timeline is on the right and not the left — what changed since Replied, post #57 · Meta › Site feedback · 18 Jun 2026 · 14 likes Feature requests: if the site would work better with a feature it does not have (better search, different filtering, new section) suggest it here with the reasoning.
-
Why side effects reset at each escalation and that is not a failure Started this topic · Practice › Side effects · 14 Jun 2026 · 0 likes Why side effects reset at each escalation and that is not a failure — that is the question, and I have not found it answered plainly anywhere I have looked. I have read…